APO LET 2.5 (Letrozole 2.5 mg)
Pill with imprint APO LET 2.5 is Yellow, Round and has been identified as Letrozole 2.5 mg. It is supplied by Apotex Corp..
Letrozole is used in the treatment of female infertility; breast cancer; breast cancer, metastatic; breast cancer, adjuvant and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for APO LET 2.5
Letrozole
- Imprint:
- APO LET 2.5
- Strength:
- 2.5 mg
- Color:
- Yellow
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Aromatase inhibitors
Hormones/antineoplastics - Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Apotex Corp.
- Inactive Ingredients:
- hydroxypropyl cellulose
hypromelloses
lactose monohydrate
magnesium stearate
microcrystalline cellulose
polyethylene glycol 8000
sodium starch glycolate type A potato
titanium dioxide
ferric oxide yellow
Note: Inactive ingredients may vary.
Other Labelers / Repackagers:
| NDC Code | Labeler / Repackager |
|---|---|
| 68084-0803 | Amerisource Health Services |
More about letrozole
- Letrozole Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 121 Reviews – Add your own review/rating
- Drug class: aromatase inhibitors
Consumer resources
Other brands: Femara
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
